““This course has greatly improved my understanding of the clinical trial process. I have worked in clinical for six years but not in this capacity. I can now speak to colleagues with greater confidence.”
"Excellent preparation for a CRA career and also useful for study managers, investigators, and study coordinators who want to work more effectively with CRAs."
Norman M. Goldfarb, Managing Director, First Clinical Research LLC
“I'm a technical trainer for a large clinical trials division and my goal in taking this course was to better understand the role played by a CRA. This course has definitely done that for me and I can see myself applying what I have learned to my
trainings. The presenter has a lot of real world knowledge and experience which she constantly applied to the course. I couldn't ask for a better speaker/trainer. Very easy to navigate and great use of technology. On a scale of 1 to 10......12!”
"The presentation was very thorough and informative. I enjoyed the delivery style and appreciate the wealth of experience the trainer draws from."
“This course has greatly improved my understanding of the clinical trial process. I have worked in clinical for six years but not in this capacity. I can now speak to colleagues with greater confidence.”
“I have been given a solid framework on how to approach future studies from site selection, protocol development, and inclusion/exclusion importance to regulatory considerations (when to report what to whom). I plan to make use of all the monitoring
tools provided to achieve success and utilize EDC for ease of CRF collection. When in doubt, I will always refer back to modules for guidance. Great course, thanks!”
“The trainer was well-equipped, knowledgeable and open to Q&A's. She provided excellent course material and spoke with great details from her current and past experience. This has been the best learning I have received as a CRA. I look forward
to more courses!”
“The information I learned in today's webinar will give me and my company an advantage with our client against other competing CROs.”